In episode 53 we discuss an article comparing treatment retention and mortality in patients who are prescribed methadone vs. buprenorphine/naloxone for treatment of opioid use disorder. 

Nosyk B, Et al. Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder. JAMA. 2024 Oct 17. 

We also discuss the Modernizing Opioid Treatment Access Act, engaging non-abstinent patients in treatment, and hostility to medications with the recovery community. 

Modernizing Opioid Treatment Access Act (MOTAA) (H.R.1359 / S. 644) 

ASAM: Engagement and Retention of Nonabstinent Patients in Substance Use Treatment 

STAT News: The recovery community says it offers refuge from opioid addiction. But it’s still hostile to lifesaving addiction medications 

--- 

This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES. 

CME: https://micaresed.org/courses/podcast-addiction-medicine-journal-club/ 

--- 

• Original theme music: composed and performed by Benjamin Kennedy 


• Audio editing: Michael Bonanno 


• Executive producer: Dr. Patrick Beeman 


• A podcast from Ars Longa Media 

--- 

This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice. 

The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group. 

• Email: addictionmedicinejournalclub@gmail.com 


• Facebook: @AddictionMedJC 


• Facebook Group: Addiction Medicine Journal Club 


• Instagram: @AddictionMedJC 


• Threads: @AddictionMedJC 


• YouTube: addictionmedicinejournalclub 


• Twitter/X: @AddictionMedJC  

Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities. 

Learn more about your ad choices. Visit megaphone.fm/adchoices